Clinical Trials in Boston

Showing 10841-10860 of 17,836 trials

Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients

NCT00137800

The primary purpose of this study is to determine whether the drug OSI-774 is less toxic and potentially as good as or better than standard chemotherapy drugs, when given to subjects with non-small cell lung cancer, who are 70 years of age or older.

Non-Small-Cell Lung Carcinoma

Dana-Farber Cancer Institute82 participantsStarted Feb 2003

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Post-Operative Ambulatory Challenge and Exercise (PACE) Trial

NCT03234933

This research study is evaluating the postoperative results in terms of quality of life and functional recovery of elderly patients after cancer surgery.

Cancer

Dana-Farber Cancer Institute27 participantsStarted Aug 2017

Boston, Massachusetts, United States

COMPLETEDPhase 3< 1 mile

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

NCT00026338

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Biological therapies such as erlotinib use different ways to stimulate the immune system and stop cancer cells from growing. Combining chemotherapy and biological therapy may kill more tumor cells. It is not yet known if gemcitabine is more effective with or without erlotinib in treating pancreatic cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of gemcitabine with and without erlotinib in treating patients who have unresectable locally advanced or metastatic pancreatic cancer.

Pancreatic Cancer

NCIC Clinical Trials Group569 participantsStarted Oct 2001

Tucson, Arizona, United States • Springdale, Arkansas, United States • Berkeley, California, United States +170 more locations

Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients

Post-Operative Ambulatory Challenge and Exercise (PACE) Trial

Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer

Find Trials by Condition in Boston

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With Hip OA Compared to Intra-articular Steroid Injections

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

Biomarkers for Breast Cancer Risk in African American Women

Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation